Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
August 7th, 2021
Here, we present an immunophenotyping strategy for the characterization of megakaryocyte differentiation, and show how that strategy allows the sorting of megakaryocytes at different stages with a fluorescence-activated cell sorter. The methodology can be applied to human primary tissues, but also to megakaryocytes generated in culture in vitro.
Hello.I am Andrea Acebes Huerta.Postdoctoral Researcher at the Platelet Research Lab part of the Health Research Institute of the Principality of Asturias, ISPA.Which is located in Oviedo, Spain.Hello.I am Laura Guti
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents an advanced immunophenotyping strategy for identifying successive stages of megakaryocyte (MK) differentiation, including increasing ploidy levels, in human primary samples and in vitro cultures. The approach utilizes a panel of MK-specific and non-specific surface markers, enabling detailed flow cytometric analysis of MK maturation beyond the identification of mature cells.
Key Study Components
Area of Science
- Hematology
- Cell Biology
- Immunophenotyping
Background
- Megakaryocytes undergo multiple endomitotic cycles, resulting in highly polyploid and large cells.
- Current flow cytometry methods are limited to identifying mature MKs using lineage-specific markers.
- Earlier stages of MK differentiation are not well characterized by flow cytometry.
- Improved characterization could aid in understanding megakaryopoiesis and related diseases.
Purpose of Study
- To develop an immunophenotyping strategy for identifying all stages of MK differentiation.
- To enable analysis of MKs with varying ploidy status in both primary and cultured samples.
- To facilitate enrichment and sorting of MKs for downstream studies.
Methods Used
- Flow cytometry with a panel of MK-specific and non-specific surface markers.
- Immunophenotyping of MKs despite their large size and fragility.
- Fluorescence-activated cell sorting (FACS) using optimized pressure and nozzle diameter conditions.
Main Results
- The strategy allows identification of successive MK differentiation stages with increasing ploidy.
- MKs can be successfully immunophenotyped and enriched using the described panel and FACS conditions.
- This approach supports multi-omics studies of megakaryopoiesis and platelet production.
- Enhanced characterization may improve diagnosis and prognosis of MK-related pathologies.
Conclusions
- The immunophenotyping strategy enables comprehensive analysis of MK differentiation stages.
- It overcomes previous limitations in flow cytometric characterization of early MKs.
- This method provides a foundation for advanced studies and clinical applications in hematology.
